Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 124 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/11/2007 First Published: 4/1/1998


1.		Phase II/III Randomized Study of Conventional vs T cell Depleted Unrelated Donor Bone Marrow Transplantation for Leukemia, Myelodysplasia, and Lymphoblastic Lymphoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				55 and under				NCI				MCV-CCHR-9504-2X DUMC-75951, NCI-G98-1388, NCT00003187

Last Modified: 7/11/2007 First Published: 2/1/2000


2.		Phase II/III Randomized Study of Processed Versus Unprocessed Unrelated Bone Marrow Transplantation in Patients With Acute or Chronic Leukemia or Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Completed				12 to 50				Other				CHIMERIC-HM01 WSU-10-02-99-M01-FB, NCT00004255


3.		Phase I/III Induction with ADR/ARA-C/VCR/PRDL and Consolidation and Maintenance with ADR/ARA-C, ADR/AZC, MePRDL/VCR/6-MP/MTX, or ARA-C for ANLL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase I				Treatment				Closed				under 50								DFCI-76006 DFCI-VAPA-10

Last Modified: 5/4/2007


4.		Phase III Randomized Study of Sequential Treatment with 3 Noncross-Resistant Chemotherapy Combinations or Standard Chemotherapy for Poor-Prognosis Intermediate Grade and Immunoblastic non-Hodgkin's Lymphoma: IDA/CDDP/ARA-C/MePRDL, IDA/VCR/BLEO/CTX/MePRDL, and IFF/DHAD/VP-16 vs Standard CHOP (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 15				NCI				MDA-DM-94017 NCI-T94-0040D, NCT00002565, T94-0040

Last Modified: 5/8/2007 First Published: 11/1/1994


5.		Phase III Randomized Study of Standard Therapy with ABCM (DOX/BCNU/CTX/L-PAM) vs Intensive Therapy with C-VAMP (CTX/VCR/DOX/MePRDL) Followed by High-Dose L-PAM (with or without TBI) with Hematopoietic Rescue, Both with IFN-A Maintenance, for Previously Untreated Myeloma (Summary Last Modified 03/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 65								MRC-LEUK-MYEL-VII EU-94030, NCT00002599

Last Modified: 6/6/2005


6.		Phase III Study of Adjuvant Low-Dose Involved-Field Radiotherapy vs No Adjuvant Therapy in Children with Hodgkin's Disease in CR Following Chemotherapy Assigned by Clinical Stage (Summary Last Modified 02/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 21 at diagnosis				NCI				CCG-5942

Last Modified: 3/10/2004


7.		Phase III Randomized Study of High-Dose Sequential Chemotherapy Followed by Peripheral Blood Stem Cell Transplantation vs Cyclophosphamide/Doxorubicin/Vincristine/Prednisone (CHOP) for Poor-Risk, Intermediate- and High-Grade Non-Hodgkin's Lymphoma (Summary Last Modified 02/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 to 65				NCI				E-2493 E2493

Last Modified: 12/5/2002


8.		Phase III Randomized Study of Early Intensification Versus Alternating Triple Chemotherapy in Patients With Intermediate-Grade or Immunoblastic Lymphoma With Poor Prognosis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 59				NCI				MDA-DM-95121 NCI-V96-1010, NCT00002835

Last Modified: 11/28/2006 First Published: 4/1/1998


9.		Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Sequential High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 60				Other				SWS-SAKK-38/97 EU-97037, NCT00003215

Last Modified: 11/7/2007 First Published: 12/1/1999


10.		Phase III Randomized Study of Chemotherapy and Radiotherapy in Children With Standard or High Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				1 to 17				NCI				DFCI-95001 DFCI-FDR001197, NCI-G99-1651, NCT00004034

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute